NumerixS Investment Technologies Inc - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 177 filers reported holding DIPLOMAT PHARMACY INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
NumerixS Investment Technologies Inc ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2018$13,000
-79.0%
900
-71.9%
0.00%
-66.7%
Q3 2018$62,000
+100.0%
3,200
+166.9%
0.01%
+71.4%
Q2 2018$31,000
-83.1%
1,199
-86.5%
0.01%
-84.4%
Q1 2018$183,000
+281.2%
8,900
+270.8%
0.04%
+309.1%
Q4 2017$48,000
-74.9%
2,400
-73.9%
0.01%
-73.8%
Q3 2017$191,000
-68.4%
9,200
-77.5%
0.04%
-52.8%
Q2 2017$604,000
+357.6%
40,800
+391.6%
0.09%
+493.3%
Q1 2017$132,000
-80.2%
8,300
-65.1%
0.02%
-82.6%
Q3 2016$666,000
+65.3%
23,780
+106.5%
0.09%
+53.6%
Q2 2016$403,00011,5160.06%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q2 2017
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 7,036,670$42,853,0001.54%
ARMISTICE CAPITAL, LLC 3,200,000$19,488,0001.23%
STEPHENS INC /AR/ 6,600,015$40,194,0000.91%
S&T BANK/PA 610,367$3,718,0000.82%
Rhenman & Partners Asset Management AB 1,203,405$7,329,0000.81%
Matarin Capital Management, LLC 701,445$4,272,0000.30%
Investors Research Corp 89,727$546,0000.28%
Advisory Services Network, LLC 598,802$3,647,0000.22%
FCG ADVISORS, LLC 34,000$207,0000.06%
EVERENCE CAPITAL MANAGEMENT INC 52,730$321,0000.05%
View complete list of DIPLOMAT PHARMACY INC shareholders